Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2017 Nov 15

PMID 29133520

Citations 7

Authors

Joshua D Mitchell

David L Brown

Affiliations

Soon will be listed here.

Citing Articles

From the armchair to contemporary cardiac rehabilitation: the remarkable ongoing journey of exercise training in ischemic heart disease.

Vilela E, Almeida M, Oliveira C, Nogueira T, Torres S, Teixeira M Porto Biomed J. 2024; 9(6):273.

PMID: 39563981 PMC: 11573334. DOI: 10.1097/j.pbj.0000000000000273.

Target and non-target vessel related events at 10 years post percutaneous coronary intervention.

Coughlan J, Aytekin A, Xhepa E, Cassese S, Joner M, Koch T Clin Res Cardiol. 2022; 111(7):787-794.

PMID: 35147767 PMC: 9242894. DOI: 10.1007/s00392-022-01986-4.

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society.

Mitchell J, Cehic D, Morgia M, Bergom C, Toohey J, Guerrero P JACC CardioOncol. 2021; 3(3):360-380.

PMID: 34604797 PMC: 8463721. DOI: 10.1016/j.jaccao.2021.06.003.

Stable ischemic heart disease: re-appraisal of coronary revascularization criteria in the light of contemporary evidence.

Orsini E, Nistri S, Zito G Cardiovasc Diagn Ther. 2020; 10(6):1992-2004.

PMID: 33381439 PMC: 7758758. DOI: 10.21037/cdt.2019.11.02.

Ethics of information-gathering interventions in innovative practice.

Earl J, Wendler D Intern Med J. 2020; 50(12):1583-1587.

PMID: 33354875 PMC: 10107679. DOI: 10.1111/imj.15117.

References

Marzilli M, Merz C, Boden W, Bonow R, Capozza P, Chilian W . Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!. J Am Coll Cardiol. 2012; 60(11):951-6. DOI: 10.1016/j.jacc.2012.02.082. View

Dagenais G, Lu J, Faxon D, Kent K, Lago R, Lezama C . Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation. 2011; 123(14):1492-500. DOI: 10.1161/CIRCULATIONAHA.110.978247. View

Teo K, Sedlis S, Boden W, ORourke R, Maron D, Hartigan P . Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation).... J Am Coll Cardiol. 2009; 54(14):1303-8. DOI: 10.1016/j.jacc.2009.07.013. View

Hultgren H, CALCIANO A, Platt F, ABRAMS H . A clinical evaluation of coronary arteriography. Am J Med. 1967; 42(2):228-47. DOI: 10.1016/0002-9343(67)90022-8. View

Sicari R, Palinkas A, Pasanisi E, Venneri L, Picano E . Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET). Eur Heart J. 2005; 26(20):2136-41. DOI: 10.1093/eurheartj/ehi408. View

Hachamovitch R, Hayes S, Friedman J, Cohen I, Berman D . Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003; 107(23):2900-7. DOI: 10.1161/01.CIR.0000072790.23090.41. View

Lin G, Dudley R, Redberg R . Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007; 167(15):1604-9. DOI: 10.1001/archinte.167.15.1604. View

Echt D, Liebson P, Mitchell L, Peters R, BARKER A, Arensberg D . Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991; 324(12):781-8. DOI: 10.1056/NEJM199103213241201. View

Maron D, Spertus J, Mancini G, Hartigan P, Sedlis S, Bates E . Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol. 2009; 104(8):1055-62. DOI: 10.1016/j.amjcard.2009.05.056. View

10.

Hueb W, Bellotti G, de Oliveira S, ARIE S, de Albuquerque C, JATENE A . The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol. 1995; 26(7):1600-5. DOI: 10.1016/0735-1097(95)00384-3. View

11.

ROBB G, Marks H, MATTINGLY T . The value of the double standard two-step exercise test in the detection of coronary disease; a clinical and statistical follow-up study of military personnel and insurance applicants. Trans Assoc Life Insur Med Dir Am. 1956; 40:52-80; discussion, 80-5. View

12.

Gruntzig A . Transluminal dilatation of coronary-artery stenosis. Lancet. 1978; 1(8058):263. DOI: 10.1016/s0140-6736(78)90500-7. View

13.

Mancini G, Bates E, Maron D, Hartigan P, Dada M, Gosselin G . Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes. 2009; 2(4):320-7. DOI: 10.1161/CIRCOUTCOMES.108.830091. View

14.

Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K . Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004; 109(11):1371-8. DOI: 10.1161/01.CIR.0000121360.31954.1F. View

15.

Shaw L, Weintraub W, Maron D, Hartigan P, Hachamovitch R, Min J . Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012; 164(2):243-50. DOI: 10.1016/j.ahj.2012.05.018. View

16.

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

17.

Levine G, Bates E, Blankenship J, Bailey S, Bittl J, Cercek B . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and.... J Am Coll Cardiol. 2011; 58(24):e44-122. DOI: 10.1016/j.jacc.2011.08.007. View

18.

Hueb W, Soares P, Gersh B, Cesar L, Luz P, Puig L . The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004; 43(10):1743-51. DOI: 10.1016/j.jacc.2003.08.065. View

19.

McNeer J, Margolis J, Lee K, Kisslo J, PETER R, Kong Y . The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation. 1978; 57(1):64-70. DOI: 10.1161/01.cir.57.1.64. View

20.

McFalls E, Ward H, Moritz T, Goldman S, Krupski W, Littooy F . Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004; 351(27):2795-804. DOI: 10.1056/NEJMoa041905. View